PG SEC Filings

Procter & Gamble reported its fiscal second-quarter results, showcasing modest revenue growth driven by price increases and favorable foreign exchange, partially offset by a slight decline in unit volume. While overall net sales saw a 1% increase year-over-year for the quarter and 2% for the six-month period, profitability faced pressure. Operating income and net earnings declined for the three-month period, impacted by unfavorable product mix, increased restructuring costs, and higher marketing spend. For the six-month period, net earnings saw a 5% increase driven by a significant favorable swing in "Other non-operating income/(expense), net," largely due to the prior year's substantial restructuring charges related to the liquidation of operations in Argentina. Despite the earnings increase, the company continues to navigate cost pressures, including tariffs and commodity costs, while investing in marketing and productivity initiatives. The company reaffirmed its expectation to reduce outstanding shares by approximately $5 billion in fiscal year 2026.

Procter & Gamble (PG) has filed a Current Report on Form 8-K, primarily disclosing information related to its second quarter financial results for fiscal year 2026. The company issued a press release on January 22, 2026, to announce these results and subsequently held a conference call with investors. This 8-K filing is being furnished under Regulation FD to provide transparency regarding the information shared during these communications. Investors should note that the core of this filing consists of informational slides that were referenced during the conference call and are also available on the company's website. The purpose of this disclosure is to ensure that all material information regarding the second quarter performance is disseminated equally to all market participants.

Procter & Gamble (PG) has filed a Current Report on Form 8-K to disclose its financial results for the quarter ended December 31, 2025. This filing primarily serves to furnish the accompanying news release, which contains the detailed earnings information investors would typically seek. Investors should review this news release for crucial updates on the company's revenue, profitability, and any management commentary regarding performance drivers and outlook. The report indicates that the company is providing this information under Item 2.02, focusing on results of operations and financial condition for the specified period. While the 8-K itself is a procedural filing, the attached news release is the substantive document containing the financial performance data. Investors should pay close attention to key metrics such as sales growth, earnings per share (EPS), and any changes in segment performance. Management's discussion within the release will likely offer insights into factors influencing these results, including market trends, competitive landscape, and strategic initiatives. This information is vital for assessing the company's ongoing operational health and its ability to meet future financial targets.

The Procter & Gamble Company (PG) has filed a Current Report on Form 8-K, primarily to announce a regular quarterly dividend declaration. The Board of Directors has approved a dividend of $1.0568 per share for both its Common Stock and its Series A and Series B ESOP Convertible Class A Preferred Stock. This dividend is scheduled to be paid on or after February 17, 2026, with record dates set for January 23, 2026, for both classes of shareholders. This disclosure is made in accordance with Regulation FD to ensure fair and timely dissemination of material information to all investors.

Procter & Gamble Co. (PG) has filed an 8-K report on December 15, 2025, announcing a significant leadership change. Jennifer Davis, the current Chief Executive Officer of the Health Care division, has informed the company of her intention to retire effective June 30, 2026. Ms. Davis has had a long and distinguished career at P&G, spanning over 33 years, contributing significantly to the company's operations, particularly within the Health Care segment.

Procter & Gamble Co. (PG) announced the successful closing of a public offering for $258.89 million in Floating Rate Notes due November 4, 2075. This offering was conducted under the company's existing Registration Statement on Form S-3. The issuance of these long-term notes signifies a strategic move to secure long-dated financing, likely to support ongoing operations, strategic investments, or capital allocation strategies. Investors should note the floating rate nature of the notes, which means interest payments will adjust over time based on prevailing market rates, potentially impacting future interest expense predictability.

The Procter & Gamble Company (PG) has announced the successful closing of multiple underwritten public offerings of senior notes. These offerings include €1 billion in Euro-denominated notes (split into €500 million due 2033 at 2.900% and €500 million due 2045 at 3.650%) and $1.25 billion in U.S. dollar-denominated notes (split into $750 million due 2032 at 4.100% and $500 million due 2035 at 4.350%). These issuances were made under the company's existing shelf registration statement on Form S-3. This move signifies P&G's proactive capital management strategy, likely aimed at refinancing existing debt, funding strategic initiatives, or strengthening its liquidity position. The issuance of both Euro and U.S. dollar notes diversifies the company's debt maturity profile and currency exposure. Investors should note the coupon rates and maturity dates, which provide insights into the cost of capital and the company's long-term financial planning. The legal opinions and consents attached as exhibits indicate that the offerings were completed in accordance with regulatory requirements.

Procter & Gamble (PG) has filed an 8-K report on October 24, 2025, primarily to disclose its first-quarter results and provide associated informational slides. The company hosted a conference call to discuss these results, and the furnished slides are also available on their corporate website. This filing serves to ensure broad dissemination of material information in compliance with Regulation FD. Investors should review the supplemental slides (Exhibit 99.1) which likely contain detailed financial performance metrics, segment results, and forward-looking commentary from management. While the 8-K itself doesn't contain the full financial statements, it directs investors to where the detailed information supporting the earnings announcement can be found, offering transparency into the company's recent performance and strategic updates.

Procter & Gamble (PG) reported solid financial results for the three months ended September 29, 2025. Net sales increased by 3% year-over-year to $22.4 billion, driven by a combination of pricing, mix, and foreign exchange benefits, with a neutral impact from volume. Net earnings saw a significant increase of 20% to $4.8 billion, primarily due to lower restructuring charges compared to the prior year's significant charges related to market portfolio restructuring. Diluted Earnings Per Share (EPS) also rose by 21% to $1.95. The company demonstrated strong operational cash flow of $5.4 billion and achieved a robust adjusted free cash flow productivity of 102%. Despite a slight decrease in gross margin due to unfavorable mix and investment in product/packaging, effective management of Selling, General & Administrative (SG&A) expenses, including productivity savings, supported operating income growth. The company continues its portfolio and productivity plan, aiming for cost structure improvements.

The Procter & Gamble Company (PG) has filed an 8-K report on October 24, 2025, primarily to disclose its earnings for the quarter ended September 30, 2025. The filing includes a news release containing the company's financial results and operational performance for the period. Investors should review this news release for detailed insights into PG's revenue, profitability, and any forward-looking statements made by management regarding future performance and strategic initiatives. This report serves as the primary vehicle for disseminating key financial information to the market. While the 8-K itself is brief, the attached news release (Exhibit 99.1) is the critical document for understanding the company's financial health and operational trends. Investors will be looking for details on sales growth, margin performance, and any impacts from macroeconomic factors or company-specific strategies. Any commentary on competitive positioning or market share will also be of significant interest.

Procter & Gamble Co. (PG) filed an 8-K on October 16, 2025, reporting on key outcomes from its 2025 Annual Meeting of Shareholders held on October 14, 2025. The most significant event for investors is the shareholder approval of the "The Procter & Gamble 2025 Stock and Incentive Compensation Plan." This new plan authorizes the award of up to 175 million shares of common stock through various award types, including restricted stock units and stock options, providing a framework for future executive and employee compensation. The filing also details the results of several other shareholder votes. All director nominees were elected, the appointment of the independent registered public accounting firm was ratified, and the advisory vote to approve executive compensation ("Say on Pay") passed. These outcomes indicate continued shareholder confidence in the company's leadership and compensation practices.

Procter & Gamble Co. (PG) has filed an 8-K report detailing key announcements made on October 13, 2025, and released on October 14, 2025. The most significant update for investors is the declaration of the quarterly dividend. The Board of Directors has approved a dividend of $1.0568 per share for both common stock and preferred ESOP stock. This dividend is payable on or after November 17, 2025, with a record date of October 24, 2025, ensuring a consistent return of capital to shareholders. In addition to the dividend, the company also announced preliminary voting results from its Annual Meeting of Shareholders. All fourteen nominated directors were elected, indicating continued confidence in the current board's leadership and governance. These announcements, made under Regulation FD, provide timely and material information to the investing public, reinforcing PG's commitment to shareholder value and stable corporate governance.

Procter & Gamble Co. (PG) has announced a significant leadership transition with the upcoming retirement of Alexandra Keith, currently CEO of the Beauty division. Ms. Keith's retirement is scheduled for February 20, 2026, concluding over 36 years of dedicated service to the company. This announcement, filed on August 13, 2025, marks the end of an era for a key executive in a major segment of P&G's business. From an investor's perspective, the key takeaway is the succession planning and the terms of Ms. Keith's departure. The company has outlined a standard Written Separation Agreement that, notably, does not include cash severance. However, Ms. Keith will be permitted to retain her special equity award scheduled to vest in August 2026, with other equity awards being handled according to their respective agreements. Investors will be watching for updates on the leadership transition within the Beauty division and the broader implications for the segment's strategic direction.

The Procter & Gamble Company (PG) reported fiscal year 2025 revenues of $84.3 billion, a slight increase of 0.3% year-over-year, driven primarily by a 1% increase in pricing, which was mostly offset by a 1% unfavorable foreign exchange impact. Organic sales grew by 2%, indicating underlying demand strength across its diverse portfolio. The company demonstrated improved profitability with a 10% increase in operating income, reaching $20.5 billion, and a 7% rise in net earnings to $16.1 billion. This improvement was largely attributed to reduced selling, general, and administrative (SG&A) costs, including a 50 basis point reduction in marketing spending as a percentage of net sales, and the absence of a significant intangible asset impairment charge recorded in the prior year. Despite challenges in certain segments like Beauty, which saw a 2% net sales decline and an 8% drop in net earnings due to unfavorable product mix and a decline in the SK-II brand, other segments like Health Care and Fabric & Home Care showed resilience. Health Care net sales grew 2% with an 8% increase in net earnings, while Fabric & Home Care net sales were stable with a 3% increase in net earnings. The company maintained a strong financial position, generating $17.8 billion in operating cash flow, though this was a 10% decrease year-over-year. Adjusted free cash flow stood at $14.6 billion, with an 87% productivity rate. P&G reaffirmed its commitment to shareholder returns, continuing its long history of dividend payments and increases, and repurchased $6.5 billion in shares during the fiscal year.

Procter & Gamble (PG) has filed an 8-K report on July 29, 2025, to furnish its earnings release for the quarter and fiscal year ended June 30, 2025. While the 8-K itself does not contain detailed financial figures, it directs investors to the accompanying news release (Exhibit 99.1) for this information. Investors should review this news release to understand the company's financial performance, including key metrics like revenue, earnings per share, and segment performance for the recently concluded periods. The filing indicates that the earnings announcement occurred on July 29, 2025, with the report filed on the same day. The primary purpose of this 8-K is to officially incorporate the earnings release into the public record, making it readily accessible for analysis. Shareholders and potential investors are encouraged to examine the details within the news release for insights into management's commentary on financial condition, operational results, and future outlook.

The Procter & Gamble Company (PG) has filed an 8-K report on July 29, 2025, to announce its fourth quarter and fiscal year 2025 financial results. This filing primarily serves to furnish informational slides used in conjunction with a conference call discussing these results, which are also available on the company's website. Investors should consult these slides for detailed commentary on the company's performance during the recently concluded fiscal year and its latest quarter, as well as any forward-looking statements or strategic updates provided by management. The 8-K itself is a procedural filing under Regulation FD, ensuring broad public access to the information shared.

Procter & Gamble Co. (PG) has announced a significant leadership transition, with current Chairman, President, and CEO Jon Moeller set to move into an Executive Chairman role effective January 1, 2026. Concurrently, Chief Operating Officer Shailesh Jejurikar will assume the positions of President and CEO, also effective January 1, 2026. This planned succession aims to ensure continuity in leadership while positioning the company for future growth under a new executive team. Mr. Jejurikar's appointment follows a long tenure with the company and a progression through various senior leadership roles, including his most recent position as COO. This filing also details the updated compensation arrangements for both executives. Mr. Jejurikar will receive a base salary of $1.6 million and a target annual incentive of 200% of base salary, along with a $14 million long-term incentive award. Mr. Moeller, in his new role, will receive a base salary of $1.2 million and a target annual incentive of 150% of base salary, with a $15 million long-term incentive award. These changes reflect the board's confidence in the new leadership structure and its commitment to retaining experienced talent.

The Procter & Gamble Company (PG) has filed an 8-K report on July 8, 2025, primarily to disclose a routine dividend declaration by its Board of Directors. This announcement confirms the company's ongoing commitment to returning capital to shareholders. Investors should note the specific details regarding the dividend amount and payment schedule, which are designed to provide clarity and transparency on expected shareholder returns. The key takeaway for investors is the declaration of a quarterly dividend of $1.0568 per share. This payment is scheduled for distribution on or after August 15, 2025, with a record date of July 18, 2025, for both Common Stock and specific ESOP Convertible Preferred Stock classes. While this filing does not contain significant new financial information or strategic updates, it reinforces P&G's consistent dividend payout policy, a factor often considered by income-focused investors.

Procter & Gamble Company (PG) announced a significant change to its Board of Directors with the appointment of Craig Arnold, former Chairman and CEO of Eaton Corporation, effective June 9, 2025. Mr. Arnold's appointment is considered a move to strengthen the board's expertise, particularly given his extensive leadership experience in a large industrial conglomerate. His immediate committee assignments include the Audit and Compensation & Leadership Development Committees, indicating his expected contributions to key governance areas. Investors should note that Mr. Arnold has been deemed independent by the Company and the NYSE, aligning with best governance practices. His compensation will be consistent with that of other non-employee directors, including a pro-rated RSU grant. This appointment, disclosed under Regulation FD via a press release, signals the company's ongoing commitment to robust corporate governance and strategic board composition. The filing also includes standard exhibit information related to the press release and interactive data.

Procter & Gamble (PG) has announced a significant, two-year restructuring program aimed at streamlining its operations and enhancing efficiency. This program, disclosed at the Deutsche Bank Global Consumer Conference, involves strategic portfolio choices, including brand exits in select markets, and substantial supply chain optimization. These actions are designed to drive efficiencies, accelerate innovation, and reduce costs. The company anticipates this initiative will lead to a reduction of up to 7,000 non-manufacturing roles, representing approximately 15% of that workforce. Financially, the restructuring is expected to result in a pre-tax charge of $1.0 to $1.6 billion over the two-year period, with about 25% of these charges being non-cash. While the specifics of brand exits are yet to be detailed, the overall program signals a strategic shift towards a more focused and efficient operational model for Procter & Gamble. Investors should monitor future disclosures for details on the brands involved and the financial impact of these charges.

The Procter & Gamble Company (PG) has announced the successful closing of a significant debt offering on April 30, 2025. The company issued $700 million in 4.050% Notes due 2030 and $550 million in 4.600% Notes due 2035, totaling $1.25 billion in aggregate principal amount. These notes were issued under the company's existing Registration Statement on Form S-3, indicating a routine capital markets transaction for PG. This offering provides PG with additional long-term financing. Investors in these notes gain exposure to P&G's creditworthiness with defined interest payments and maturity dates. The details of the offering, including the specific interest rates and maturity terms, are now publicly disclosed, offering transparency to stakeholders regarding the company's capital structure and financing activities. The filing also includes supporting legal opinions as exhibits.

Procter & Gamble (PG) has filed an 8-K report on April 24, 2025, primarily to furnish a news release concerning their financial results for the quarter ended March 31, 2025. This filing provides investors with key operational and financial performance data for the period. While the full details of the earnings are contained within the furnished news release (Exhibit 99.1), the 8-K itself serves as the official notification and mechanism for disseminating this information to the market.

Procter & Gamble Co. (PG) has filed an 8-K report on April 24, 2025, primarily to disclose its third-quarter financial results and provide related materials. The company issued a press release detailing these results and held a conference call to discuss them. This filing, made under Regulation FD, includes informational slides that were referenced during the conference call and are also available on the company's website, offering investors a direct look at the company's performance and management's commentary. Investors should note that this 8-K is primarily a furnishing of information rather than an announcement of new material events, focusing on the dissemination of already-released quarterly performance data. The accompanying slides (Exhibit 99.1) are the key takeaway for investors seeking to understand the detailed financial performance, segment results, and any forward-looking statements or strategic insights shared by PG's management for the third quarter of the fiscal year.

Procter & Gamble (PG) reported its fiscal third-quarter and nine-month results ending March 31, 2025. For the quarter, net sales slightly decreased by 2% to $19.8 billion, primarily due to unfavorable foreign exchange and a slight decline in unit volume, though this was partially offset by higher pricing. Net earnings remained flat year-over-year at $3.8 billion, with diluted Earnings Per Share (EPS) increasing 1% to $1.54. For the nine-month period, net sales saw a marginal decrease of $112 million to $63.4 billion, while net earnings increased by 5% to $12.4 billion, and diluted EPS rose by 6% to $5.03. The year-over-year improvement in earnings was significantly influenced by the absence of a large intangible asset impairment charge in the prior year, partially offset by current year restructuring charges. The company's performance demonstrates resilience in a challenging global economic environment, with strategic pricing actions helping to offset volume and currency headwinds. The Fabric & Home Care segment remained the largest contributor to net sales, while the Health Care segment showed positive organic sales growth. Investors will note the continued focus on productivity savings and disciplined cost management, alongside a stable operating cash flow generation, which supports ongoing capital allocation strategies like share repurchases and dividends.

The Procter & Gamble Company (PG) has filed an 8-K Current Report on April 8, 2025, primarily announcing the declaration of its quarterly dividend. The Board of Directors has approved a dividend of $1.0568 per share for its common stock and ESOP convertible preferred stock. This dividend is payable on or after May 15, 2025. Shareholders of record as of the close of business on April 21, 2025 (for common stock) and start of business on April 21, 2025 (for preferred stock) will be eligible to receive this payment. The filing serves as a Regulation FD disclosure, ensuring consistent information dissemination to investors.

Procter & Gamble Co. (PG) reported solid results for the second quarter of fiscal year 2025, demonstrating continued resilience and growth. Net sales increased by 2% to $21.9 billion for the three months ended December 31, 2024, driven by a combination of unit volume and favorable product mix. For the six-month period, net sales grew 1% to $43.6 billion. Diluted Earnings Per Share (EPS) saw a significant increase of 34% to $1.88 for the quarter, largely influenced by the absence of a prior year intangible asset impairment charge. The company's core EPS, which excludes certain charges, also showed growth, increasing by 2% for the quarter and 4% for the six-month period, reflecting underlying operational strength. Key operational highlights include continued strength in the Health Care and Baby, Feminine & Family Care segments, with notable growth in Personal Care within the Beauty segment. The company also reported strong operating cash flow of $9.1 billion for the six-month period, underscoring its robust cash generation capabilities. P&G continues to focus on productivity improvements and strategic investments, while also managing currency fluctuations and commodity cost pressures. The company reaffirmed its commitment to returning value to shareholders through dividends and share repurchases, signaling confidence in its ongoing performance and future outlook.

Procter & Gamble (PG) has filed an 8-K report on January 22, 2025, primarily to announce its financial results for the quarter ended December 31, 2024. This filing is a routine update and is furnished as per Item 2.02 of the SEC regulations, indicating the release of earnings information through a press release. Investors should refer to the furnished press release (Exhibit 99.1) for detailed operational and financial performance metrics, including revenue, earnings per share, and any forward-looking guidance provided by the company for upcoming periods.

Procter & Gamble (PG) has filed an 8-K report on January 22, 2025, primarily to disclose its second-quarter financial results and related information through a press release and a conference call. The company is furnishing a series of informational slides used during the conference call as an exhibit to this filing. Investors should refer to these slides, which are also available on the company's website, for detailed insights into the second-quarter performance. This filing serves as a mechanism to ensure widespread dissemination of material information, in line with Regulation FD. While the 8-K itself does not contain the detailed financial figures, it directs investors to the furnished exhibits and the company's website for comprehensive information regarding the second-quarter earnings and any associated management commentary. Investors seeking specifics on PG's financial health and operational performance for the second quarter should consult the press release and the presented slides.

Procter & Gamble (PG) has announced its quarterly dividend, a routine but important update for its shareholders. The Board of Directors has declared a dividend of $1.0065 per share, payable on or after February 18, 2025. This announcement, filed on January 14, 2025, provides clarity on the expected return of capital to investors. This filing, made under Regulation FD, ensures all investors receive this information simultaneously. While the dividend amount is a key figure, the filing does not contain any significant financial performance updates or strategic shifts. Investors should note the record date of January 24, 2025, for both Common Stock and preferred shareholders to be eligible for this payout.

The Procter & Gamble Company (PG) has announced the successful closing of a significant debt offering, raising a total of $1.0 billion. This offering consisted of two tranches: $500 million in 4.150% Notes due in 2029 and $500 million in 4.550% Notes due in 2034. This move is part of the company's ongoing capital management strategy and was executed under its existing shelf registration statement on Form S-3. Investors should note that this debt issuance represents a strategic financing activity to support the company's operations and potential future investments. The fixed coupon rates provide certainty regarding future interest expenses. The company has provided legal opinions and consents as exhibits to this filing, indicating the transaction was completed with appropriate legal and regulatory oversight. This filing primarily serves to inform stakeholders about the completion of this financing event.

Procter & Gamble's (PG) Q1 fiscal year 2025 report shows a slight decrease in net sales to $21.7 billion, down 1% year-over-year. This decline was primarily driven by unfavorable foreign exchange and a slight decrease in unit volume, though offset by a 1% increase in pricing. On an organic basis, sales increased by 2%, indicating underlying business strength. Net earnings attributable to P&G decreased by 12% to $4.0 billion, largely due to significant restructuring charges of $0.8 billion after tax related to the liquidation of operations in Argentina. Excluding these one-time charges, Core Diluted EPS saw a positive increase of 5% to $1.93, highlighting the company's ability to manage profitability even amidst challenging market conditions. The company maintained strong operating cash flow of $4.3 billion and is committed to returning capital to shareholders through dividends and share repurchases.

Procter & Gamble Co. (PG) filed an 8-K on October 18, 2024, to furnish a press release and accompanying informational slides detailing its first-quarter financial results. The filing, made under Regulation FD, highlights the company's proactive approach to transparently sharing important financial information with investors concurrently with its earnings announcement and conference call. Investors should refer to the furnished exhibits for a comprehensive overview of the company's performance and forward-looking statements. The primary purpose of this 8-K is to make the detailed financial results and associated presentation materials publicly available. While the 8-K itself does not contain new financial data beyond referencing the press release and slides, it serves as an official record of the information disseminated during the earnings call. Investors seeking specific quarterly figures, operational updates, and management commentary are directed to the referenced press release and the detailed slides provided as an exhibit.

The Procter & Gamble Company (PG) filed an 8-K on October 18, 2024, to report its earnings for the quarter ended September 30, 2024. This filing primarily serves to attach the earnings release, which provides investors with the company's financial and operational performance for the period. Investors should refer to the accompanying news release (Exhibit 99.1) for detailed financial results, including revenue, earnings per share, and segment performance, as well as management's commentary on business outlook and strategic initiatives. The core purpose of this 8-K is to make the earnings announcement publicly available and compliant with SEC regulations. While the 8-K itself is brief, it signifies that P&G has disclosed key financial metrics and operational updates. Investors are encouraged to review the full earnings release for a comprehensive understanding of the company's performance and future expectations.

This 8-K filing from Procter & Gamble Co. (PG) details the outcomes of its 2024 Annual Meeting of Shareholders held on October 8, 2024. The primary focus is on the voting results for key proposals presented to shareholders. All director nominees were overwhelmingly elected to serve one-year terms on the Board, indicating strong shareholder confidence in the current leadership. Furthermore, shareholders ratified the appointment of the company's independent registered public accounting firm and approved the executive compensation plan through the "Say on Pay" advisory vote. These outcomes suggest shareholder alignment with the company's governance and financial strategies. However, a shareholder proposal regarding Pay Gap Reporting did not receive majority support, reflecting a divergence of opinion on this specific issue.

Procter & Gamble (PG) announced its quarterly dividend on October 8, 2024. The Board of Directors has declared a dividend of $1.0065 per share for common and certain preferred stockholders. This dividend underscores the company's continued commitment to returning capital to its shareholders, a key aspect of its investment profile. This announcement is being made under Regulation FD to ensure broad and equitable dissemination of the information. Investors should note the record and payment dates to ensure they are eligible to receive this distribution. The regular declaration of dividends is a positive signal regarding the company's financial health and its confidence in future earnings.

The Procter & Gamble Company (PG) filed its 10-K for the fiscal year ended June 30, 2024, reporting net sales of $84.0 billion, a 2% increase year-over-year, driven by a 4% increase in organic sales. Net earnings grew 2% to $15.0 billion, while core earnings per share (EPS) saw a more robust 12% increase to $6.59, benefiting from the exclusion of significant one-time charges, including a $1.3 billion impairment charge related to the Gillette intangible asset and incremental restructuring costs. The company demonstrated strong cash flow generation, with operating cash flow increasing 18% to $19.8 billion and adjusted free cash flow up 21% to $16.9 billion. P&G continues to return value to shareholders, with its share repurchase program completing its target for fiscal year 2024. The company also highlighted its consistent dividend payments, with 134 consecutive years of payments and 68 consecutive annual increases. Key risks highlighted include macroeconomic volatility, foreign currency fluctuations, supply chain disruptions, and competitive pressures. The company is actively managing these risks through productivity improvements, innovation, and strategic portfolio adjustments, such as the recent limited market portfolio restructuring in Argentina and Nigeria. P&G also disclosed an intangible asset impairment charge of $1.3 billion related to the Gillette brand, which impacted reported earnings but was excluded from core EPS.

Procter & Gamble (PG) filed an 8-K on July 30, 2024, to report on its financial results for the fiscal quarter and year ended June 30, 2024. The primary driver of this filing is the accompanying press release which details the company's performance. Investors should closely examine this press release for key metrics such as revenue, earnings per share (EPS), and any forward-looking guidance provided by management. The 8-K itself is a procedural filing, but the information contained within the furnished press release is crucial for understanding PG's recent operational success and future outlook. While the 8-K filing does not provide the detailed financial statements, it serves as notification that the company has disclosed its quarterly and annual results. Investors are advised to access the furnished press release (Exhibit 99.1) for a comprehensive understanding of PG's financial condition and operational results. This includes any commentary on segment performance, market trends impacting the business, and strategic initiatives that may have contributed to the reported figures. Understanding these elements will be key to assessing the company's ongoing value and investment potential.

The Procter & Gamble Company (PG) filed an 8-K on July 30, 2024, primarily to disclose its fourth quarter and full-year results for fiscal year 2024. The filing includes a press release and a series of informational slides that were referenced during a conference call. These materials provide key financial and operational updates for investors, offering insights into the company's performance and outlook. Investors should review the furnished slides (Exhibit 99.1) for detailed performance metrics, segment results, and any forward-looking statements or guidance. While this 8-K itself does not contain new material financial statements or quantitative data beyond what is presented in the supplemental materials, it serves as the official record for the dissemination of this important fourth-quarter information.

The Procter & Gamble Company (PG) announced on July 9, 2024, that its Board of Directors has declared a quarterly dividend. This is a routine disclosure under Regulation FD, providing timely information to the market regarding shareholder distributions. The dividend amount is set at $1.0065 per share for both common stock and its Series A and Series B ESOP Convertible Class A Preferred Stock. Investors should note the payment and record dates for this dividend. The dividend is payable on or after August 15, 2024. The record date for common stockholders is July 19, 2024, at the close of business, and for preferred stockholders, it is the start of business on the same date. This filing does not contain new financial results or significant business updates, primarily serving to inform shareholders about the upcoming dividend.

Procter & Gamble (PG) announced the closing of an underwritten public offering of senior notes on April 29, 2024. The company successfully raised €650 million in 3.150% Notes due 2028 and €850 million in 3.200% Notes due 2034. This offering was conducted under the company's existing Form S-3 Registration Statement, indicating that PG has established a shelf registration for its debt issuances. This transaction provides PG with additional capital, which can be used for general corporate purposes, including potential future investments, debt refinancing, or operational needs. The issuance of long-term debt at these interest rates reflects PG's access to capital markets and its creditworthiness. Investors should note that the specific use of these funds will likely be detailed in future financial reports or investor communications, but this issuance generally signifies a proactive approach to managing the company's financial structure and liquidity.

Procter & Gamble Co. (PG) reported solid financial results for the third quarter and nine months ended March 31, 2024. Net sales saw a modest increase of 1% for the quarter and 3% for the nine-month period, driven by strategic pricing initiatives that offset some foreign exchange headwinds and flat unit volumes. The company demonstrated strong operational execution, evidenced by significant improvements in gross margin, primarily due to manufacturing productivity savings and lower commodity costs. Profitability showed a healthy upward trend, with net earnings attributable to Procter & Gamble increasing by 11% for the quarter and 4% for the nine-month period. Diluted Earnings Per Share (EPS) also saw substantial growth. The company continued its commitment to returning value to shareholders through share repurchases and dividends, supported by robust operating cash flow of $14.1 billion for the nine months. A key event impacting earnings was a $1.3 billion pre-tax impairment charge on the Gillette intangible asset, which was noted as a non-recurring item impacting the nine-month results. Management highlighted the strength across several business segments, with Fabric & Home Care and Baby, Feminine & Family Care showing particularly strong earnings growth for the nine-month period. The company remains focused on productivity, pricing, and innovation to navigate the complex global economic landscape, which includes managing currency fluctuations and cost pressures. Overall, PG presented a picture of resilience and continued strategic focus on driving profitable growth.

This 8-K filing from Procter & Gamble (PG) announces the company's earnings for the quarter ended March 31, 2024. The primary purpose of this filing is to provide investors with the official earnings release, which contains detailed financial results and operational performance for the period. Investors should refer to the furnished news release (Exhibit 99.1) for specific financial metrics, including revenue, earnings per share, and any commentary from management regarding segment performance and outlook. While this 8-K itself is procedural, it signals the release of key financial information that will be crucial for evaluating PG's recent performance and future prospects. Investors are encouraged to review the accompanying press release for a comprehensive understanding of the company's third fiscal quarter results and any forward-looking statements or guidance provided.

This 8-K filing from Procter & Gamble (PG) primarily serves to announce the company's third-quarter financial results and provide supporting materials for a related conference call. The key takeaway for investors is that the company is disclosing its Q3 performance and the associated informational slides, which are publicly available. This filing doesn't introduce new strategic initiatives or significant corporate events beyond the regular earnings release and conference call. Investors should review the furnished informational slides (Exhibit 99.1) for detailed insights into P&G's third-quarter performance, including financial metrics, segment results, and potentially forward-looking statements or guidance. This material is crucial for understanding the company's operational health and future outlook.

Procter & Gamble (PG) has announced the upcoming retirement of a board member, Angela F. Braly, effective June 11, 2024. Ms. Braly's departure from the Board of Directors is a personal decision to allow her more time for other activities and personal pursuits. While this is a change in board composition, the filing indicates it does not stem from any disagreements or issues regarding company operations or financial performance. Investors should note this as a routine board transition. This announcement falls under Item 5.02(b) of the 8-K, which covers the departure of directors or certain officers. The filing is straightforward and does not contain any material financial updates, operational changes, or strategic shifts. The primary takeaway for investors is the upcoming change in board membership and the reason cited for Ms. Braly's retirement.

Procter & Gamble Company (PG) filed an 8-K on April 9, 2024, primarily to announce a routine quarterly dividend declaration. The Board of Directors approved a dividend of $1.0065 per share for common stock and certain preferred stock. This dividend is payable on or after May 15, 2024, with a record date of April 19, 2024. This filing serves as a Regulation FD disclosure, ensuring all investors receive this important information simultaneously. While this 8-K does not contain new financial results or significant business updates, the dividend announcement is a key indicator for investors, particularly income-focused ones. It reaffirms the company's commitment to returning capital to shareholders and highlights the stability of its dividend payout, a common characteristic of established consumer staples companies like P&G.

Procter & Gamble (PG) announced the closing of a significant debt offering on January 29, 2024. The company successfully raised a total of $1.35 billion through the issuance of two tranches of senior notes: $600 million in 4.350% Notes due 2029 and $750 million in 4.550% Notes due 2034. These offerings were conducted under the company's existing shelf registration statement. The purpose of this debt issuance is not explicitly stated in this filing but is typically used by large corporations for general corporate purposes, such as refinancing existing debt, funding strategic initiatives, acquisitions, or capital expenditures. Investors should note the specific interest rates and maturity dates of these new notes, which will impact PG's future interest expense and cash flow obligations.

Procter & Gamble's (PG) fiscal second quarter 2024 report reveals a 3% increase in net sales to $21.4 billion, driven by a 4% increase in pricing, partially offset by a 1% unfavorable foreign exchange impact. While overall net sales grew, diluted earnings per share (EPS) saw a 12% decrease to $1.40, primarily impacted by a significant $1.3 billion (pre-tax) impairment charge on the Gillette intangible asset. However, the company reported strong operational performance, with gross margin improving by 520 basis points due to manufacturing productivity, lower commodity costs, and higher pricing. Furthermore, Core EPS, which excludes the impairment charge and incremental restructuring costs, increased by a robust 16% to $1.84, highlighting the underlying strength of the business. For the first six months of the fiscal year, net sales increased by 5% to $43.3 billion, and net earnings rose by 2% to $8.0 billion. Core EPS for the six-month period surged by 16% to $3.66. The company also demonstrated strong cash flow generation, with operating cash flow at $10.0 billion and adjusted free cash flow at $8.7 billion for the first half of the fiscal year, resulting in an impressive adjusted free cash flow productivity of 96%. The company continues its share repurchase program, returning capital to shareholders.

Procter & Gamble (PG) filed an 8-K on January 23, 2024, to announce its second quarter financial results and host a related conference call. The filing primarily serves as a Regulation FD disclosure, furnishing a series of informational slides that were referenced during the call and are also available on the company's website. Investors should refer to these slides for detailed commentary and data regarding the company's recent performance. While the 8-K itself does not contain the full financial results, it directs investors to the accompanying slides (Exhibit 99.1) for comprehensive information. These slides likely cover key financial metrics, operational highlights, and forward-looking statements relevant to the second quarter of fiscal year 2024. Investors seeking to understand PG's latest performance and strategic updates should consult these furnished materials.

Procter & Gamble (PG) filed an 8-K on January 23, 2024, primarily to furnish a press release detailing its financial results for the quarter ended December 31, 2023. This filing provides investors with key operational and financial performance metrics for the period. While the 8-K itself doesn't contain the detailed financial statements or narrative analysis, it directs stakeholders to the accompanying press release (Exhibit 99.1) for this crucial information. Investors should carefully review the January 23, 2024, press release to understand P&G's sales, earnings, and any forward-looking guidance provided by management for the current fiscal year. This report serves as the official notification from the company regarding its latest financial performance, influencing investment decisions and market expectations.

Procter & Gamble (PG) filed an 8-K on January 9, 2024, to disclose its quarterly dividend declaration. The Board of Directors approved a dividend of $0.9407 per share for common stockholders and holders of its Series A and Series B ESOP Convertible Class A Preferred Stock. This dividend payment underscores the company's consistent commitment to returning capital to shareholders. The record date for common stock shareholders is January 19, 2024, with payment expected on or after February 15, 2024. Investors should note this is a routine disclosure, but important for income-focused investors tracking dividend payments.